FORNARINI, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 548
AS - Asia 75
SA - Sud America 9
NA - Nord America 7
AF - Africa 1
Totale 640
Nazione #
IT - Italia 546
SG - Singapore 30
VN - Vietnam 24
CN - Cina 17
BR - Brasile 7
US - Stati Uniti d'America 4
MX - Messico 3
AR - Argentina 2
ID - Indonesia 2
BD - Bangladesh 1
DZ - Algeria 1
GB - Regno Unito 1
HK - Hong Kong 1
RU - Federazione Russa 1
Totale 640
Città #
Genoa 436
Vado Ligure 85
Rapallo 18
Ho Chi Minh City 13
Beijing 8
Ashburn 4
Hanoi 4
Singapore 4
Arenzano 2
Biên Hòa 2
Haiphong 2
Milan 2
Bordighera 1
Centro Municipality 1
Chlef 1
Curitiba 1
Guadalupe 1
Hong Kong 1
Lagarto 1
Lomas de Zamora 1
London 1
Long An 1
Malyshevo 1
Mexico City 1
Mogi Mirim 1
Ninh Bình 1
Nortelândia 1
San Juan 1
São José do Rio Preto 1
São Paulo 1
Tây Ninh 1
Vitória 1
Totale 600
Nome #
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review 90
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 79
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 78
Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study 64
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients 61
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT 57
The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients 47
Neuroendocrine differentiation of prostate cancer is not systematically associated with increased 18f-fdg uptake 46
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials 42
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 41
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 35
Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed Tomography 14
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 8
Totale 662
Categoria #
all - tutte 2.880
article - articoli 2.880
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202325 0 0 0 0 0 0 0 0 0 9 16 0
2023/202470 3 3 5 10 5 8 1 6 2 7 5 15
2024/2025286 16 14 15 10 15 26 18 67 16 17 39 33
2025/2026281 68 38 46 46 75 8 0 0 0 0 0 0
Totale 662